Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04071457 |
|---|---|
| Brief Title: | S1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duration (DRAMMATIC) |
| First Submitted : | August 7, 2019 |
| First Submitted that Met QC Criteria : | August 26, 2019 |
| First Posted : | August 28, 2019 |
| Last Update Submitted that Met QC Criteria : | November 8, 2021 |
| Last Update Posted : | November 9, 2021 |